Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study

Title
Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study
Authors
Keywords
Magnetic resonance imaging, Mesenchymal stem cells, Respiratory infections, Evoked potentials, Multiple sclerosis, Stem cell therapy, Lesions, Stem cell transplantation
Journal
PLoS One
Volume 13, Issue 5, Pages e0195891
Publisher
Public Library of Science (PLoS)
Online
2018-05-17
DOI
10.1371/journal.pone.0195891

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started